Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug ResistanceZhuo‐Xun Wu, Zhe‐Sheng Chen|Cancers|2020Cited by 45
M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer CellsZhuo‐Xun Wu, Zhe‐Sheng Chen|Frontiers in Oncology|2020Cited by 30
Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell LineZhuo‐Xun Wu, Zhe‐Sheng Chen|Frontiers in Oncology|2021Cited by 30
Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer CellsZhuo‐Xun Wu, Jianye Zhang|Frontiers in Pharmacology|2021Cited by 26
Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) InhibitorZhuo‐Xun Wu, Zhe‐Sheng Chen|Frontiers in Cell and Developmental Biology|2021Cited by 26